Purchase this article with an account.
Alfredo Piñeyro-Garza, Salvador Lopez-Rubio, Manuel A de Alba; Phacoemulsification combined with cyclodyalisis in patients with cataract and open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2014;55(13):6128.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Retrospective study to evaluate the effects on the intraocular pressure (IOP) in hispanic patients with cataract and open angle glaucoma after phacoemulsification and implantation of an intraocular lens combined with cyclodyalisis.
Twenty-six eyes of 22 patients with chronic open-angle glaucoma and coexisting cataract were included in the study. All surgeries were performed by the same surgeon, with the same equipment, and in the same institution. Preoperative mean IOP of the 26 eyes was 18.3 +/- 4.8 mmHg with an average of 3.07 +/- 1.2 ocular anti-glaucoma medications. Data from postoperative examinations at 1 day, 1 month, 3 months, 6 months, 9 months and 12 months were collected.
Mean preoperative IOP was 18.35 +/-4.8 mmHg, the day after surgery it was 13.07 +/-5.65, at one month it was 15.96 +/-5.68, at three months 14.15+/-2.82, at six months 14.15+/-3.35, at month nine it was 14.43 +/-3.31, and one year after the surgery the mean IOP was 14.33+/- 3.31. The mean use of anti-glaucoma drops was 3.07+/-1.23 before surgery and one month after it was 1.19+/-1.23, at three months it was 1.61+/-1.32, at six months 1.73+/-1.18, at month nine 1.74 +/- 1.29 and one year after the surgery the mean use of anti-glaucoma drugs was 1.62+/- 1.28. There were no complications such as shallow anterior chamber, choroidal detachment, malignant glaucoma, hypotonic maculopathy, or endophthalmitis.
In this study we found a mean IOP reduction of 22% at one year after the surgery was performed, there was also a 50% reduction on the need of anti-glaucoma medication. We also did not have the typical complications of the phacoemulsification combined with trabeculectomy, so we consider this could be an effective, useful and safe procedure to treat patients with cataract and open angle glaucoma.
This PDF is available to Subscribers Only